The Effects of Hypolipemic and Antidiabetic Treatment on Cytokines
Status:
Unknown status
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
The study is planned to show whether combined hypolipemic and antidiabetic therapy with
various daily dosages influence the fasting plasma glucose, insulin sensitivity and
proinflammatory cytokines in diabetic and dyslipidemic subjects.